1. A 23‐Gene Classifier urine test for prostate cancer prognosis. Issue 3 (1st March 2021) Authors: Guo, Jinan; Johnson, Heather; Zhang, Xuhui; Feng, Xiaoyan; Zhang, Heqiu; Simoulis, Athanasios; Wu, Alan HB; Xia, Taolin; Li, Fei; Tan, Wanlong; Johnson, Allan; Dizeyi, Nishtman; Abrahamsson, Per‐Anders; Kenner, Lukas; Chen, Lingwu; Zhong, Wanmei; Xiao, Kefeng; Persson, Jenny L.; Zou, Chang Journal: Clinical and translational medicine Issue: Volume 11:Issue 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation. (4th July 2022) Authors: Augé, Céline; Dizeyi, Nishtman; Ramnemark, Lena; Lluel, Philippe; Grabe, Magnus Journal: Scandinavian journal of urology Issue: Volume 56:Number 4(2022) Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study. (25th July 2019) Authors: Dizeyi, Nishtman; Mattisson, Ingrid Yao; Ramnemark, Lena; Grabe, Magnus; Abrahamsson, Per‐Anders Journal: Phytotherapy research Issue: Volume 33:Number 9(2019) Page Start: 2457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer. Issue 6 (16th August 2019) Authors: Larsson, Per; Syed Khaja, Azharuddin Sajid; Semenas, Julius; Wang, Tianyan; Sarwar, Martuza; Dizeyi, Nishtman; Simoulis, Athanasios; Hedblom, Andreas; Wai, Sun Nyunt; Ødum, Niels; Persson, Jenny L. Journal: International journal of cancer Issue: Volume 146:Issue 6(2020) Page Start: 1686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗